Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis

Masashi Morita(Cancer Research UK), Gordon Stamp(Imperial College London), Peter Robins(Cancer Research UK), Anna Dulic(Cancer Research UK), Ian Rosewell(Cancer Research UK), Geza Hrivnak(Cancer Research UK), Graham Daly(Cancer Research UK), Tomas Lindahl(Cancer Research UK), Deborah E. Barnes(Cancer Research UK)
Molecular and Cellular Biology
July 14, 2004
Cited by 382Open Access
Full Text

Abstract

TREX1, originally designated DNase III, was isolated as a major nuclear DNA-specific 3'-->5' exonuclease that is widely distributed in both proliferating and nonproliferating mammalian tissues. The cognate cDNA shows homology to the editing subunit of the Escherichia coli replicative DNA polymerase III holoenzyme and encodes an exonuclease which was able to serve a DNA-editing function in vitro, promoting rejoining of a 3' mismatched residue in a reconstituted DNA base excision repair system. Here we report the generation of gene-targeted Trex1(-/-) mice. The null mice are viable and do not show the increase in spontaneous mutation frequency or cancer incidence that would be predicted if Trex1 served an obligatory role of editing mismatched 3' termini generated during DNA repair or DNA replication in vivo. Unexpectedly, Trex1(-/-) mice exhibit a dramatically reduced survival and develop inflammatory myocarditis leading to progressive, often dilated, cardiomyopathy and circulatory failure.


Related Papers

No related papers found

Powered by citation graph analysis